WhitTier Trust Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-33,550
Closed -$3.33M 1037
2019
Q3
$3.33M Buy
33,550
+150
+0.4% +$14.3K 0.23% 101
2019
Q2
$3.09M Buy
33,400
+196
+0.6% +$18.6K 0.22% 106
2019
Q1
$3.13M Buy
33,204
+356
+1% +$31.1K 0.23% 106
2018
Q4
$2.11M Sell
32,848
-1,434
-4% -$106K 0.17% 122
2018
Q3
$3.07M Sell
34,282
-54
-0.2% -$4.77K 0.22% 109
2018
Q2
$2.73M Buy
34,336
+123
+0.4% +$10.2K 0.21% 114
2018
Q1
$3.05M Buy
34,213
+510
+2% +$49K 0.25% 101
2017
Q4
$3.52M Sell
33,703
-9,461
-22% -$1.07M 0.3% 92
2017
Q3
$6.29M Buy
43,164
+538
+1% +$73.3K 0.59% 51
2017
Q2
$5.54M Buy
42,626
+714
+2% +$87.5K 0.54% 57
2017
Q1
$5.21M Sell
41,912
-3,257
-7% -$390K 0.52% 58
2016
Q4
$5.23M Buy
45,169
+171
+0.4% +$19K 0.56% 52
2016
Q3
$4.7M Sell
44,998
-1,935
-4% -$209K 0.53% 57
2016
Q2
$4.63M Buy
46,933
+1,055
+2% +$109K 0.53% 59
2016
Q1
$4.59M Sell
45,878
-59
-0.1% -$6.08K 0.54% 57
2015
Q4
$5.5M Buy
45,937
+4,260
+10% +$493K 0.64% 49
2015
Q3
$4.51M Buy
41,677
+2,263
+6% +$281K 0.55% 56
2015
Q2
$4.56M Buy
39,414
+2,953
+8% +$338K 0.51% 63
2015
Q1
$4.2M Sell
36,461
-200
-0.5% -$23.9K 0.47% 69
2014
Q4
$4.1M Sell
36,661
-191
-0.5% -$20.1K 0.46% 68
2014
Q3
$3.49M Buy
36,852
+312
+0.9% +$28.2K 0.4% 73
2014
Q2
$3.14M Sell
36,540
-2,316
-6% -$176K 0.35% 76
2014
Q1
$2.71M Buy
38,856
+2,556
+7% +$202K 0.32% 81
2013
Q4
$3.07M Sell
36,300
-2,234
-6% -$177K 0.37% 76
2013
Q3
$2.97M Buy
38,534
+3,398
+10% +$238K 0.4% 75
2013
Q2
$2.06M Buy
+35,136
New +$2.11M 0.3% 82

Other funds holding CELG

WhitTier Trust Company's CELG Position: Q4 2019 in Review

WhitTier Trust Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 33,550 shares — an estimated $3.33M sold.

WhitTier Trust Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.29M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • WhitTier Trust Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • WhitTier Trust Company sold 33,550 Celgene Corp shares in Q4 2019, an estimated $3.33M.
  • WhitTier Trust Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • WhitTier Trust Company's Celgene Corp position peaked at $6.29M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on WhitTier Trust Company's 13F filing for Q4 2019, filed 31 Jan 2020.